This paper is in the following e-collection/theme issue:

Systematic Review Protocols (268) Drug Repurposing and Off-Label Use (25)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/38658, first published .
The Efficacy, Safety, and Efficiency of the Off-Label Use of Bevacizumab in Patients Diagnosed With Age-Related Macular Degeneration: Protocol for a Systematic Review and Meta-Analysis

The Efficacy, Safety, and Efficiency of the Off-Label Use of Bevacizumab in Patients Diagnosed With Age-Related Macular Degeneration: Protocol for a Systematic Review and Meta-Analysis

The Efficacy, Safety, and Efficiency of the Off-Label Use of Bevacizumab in Patients Diagnosed With Age-Related Macular Degeneration: Protocol for a Systematic Review and Meta-Analysis

Authors of this article:

João Estarreja1 Author Orcid Image ;   Priscila Mendes1 Author Orcid Image ;   Carina Silva1, 2 Author Orcid Image ;   Pedro Camacho1 Author Orcid Image ;   Vanessa Mateus1, 3 Author Orcid Image
Article Authors Cited by (2) Tweetations (2) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.